ALFA FinderNSE filing, NSE: AARTIDRUGS. Summary written from the filing by ALFA Finder's alert engine.
Aarti Drugs Ltd: key numbers
- Share price
- ₹446.75
- Market cap
- ₹4,077 Cr
- Revenue (annual)
- ₹2,565 Cr
- Net profit (annual)
- ₹194.9 Cr
- P/E (TTM)
- 17.8×Sector 43.0×
- Promoter holding
- 54.07%-0.36% QoQ
- FII holding
- 2.26%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aarti Drugs Ltd
All →Aarti Drugs Business Update
Aarti Drugs disclosed that the US FDA inspected its subsidiary Pinnacle Life Science's Baddi plant on 2-6 November 2026 and issued three Form 483 observations. The company states there is no financial or operational impact.
Aarti Drugs Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue Rs 826.2 Cr (+27% YoY), EBITDA Rs 137.9 Cr (16.6% margin, +370 bps), PAT Rs 82.8 Cr (+83%). Specialty chemicals nearly doubled; formulations grew 58%.
Aarti Drugs Results Update
Aarti Drugs reports Q2 FY27 revenue of ₹828.8 Crore and PAT of ₹82.8 Crore, up 83% YoY. Results reflect record quarterly EBITDA and margin expansion.
Aarti Drugs Q2 FY27 Results: Net Profit ₹82.8 Cr, Up 83.2% YoY
Aarti Drugs Ltd reported revenue from operations of ₹826.2 Cr (+26.6% YoY) and net profit of ₹82.8 Cr (+83.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹82.8 Cr · +83.2% YoY
Aarti Drugs Board Meeting Date
Aarti Drugs Ltd intimated BSE and NSE of a board meeting on November 3, 2026, to consider audited financial results for the quarter and half year ended September 30, 2026. Trading window remains closed until 48 hours after results declaration.
Aarti Drugs Other Announcement
The company submitted its quarterly shareholding pattern as of September 30, 2026, in compliance with SEBI Listing Regulations.
Other legal & regulatory announcements
All →Tata Power Company Legal & Regulatory
Tata Power discloses Singapore court developments in its Kleros arbitration, including share attachment notices to two subsidiaries. Detailed appeal submissions are due November 23, 2026.
Baroda Rayon Corporation Legal & Regulatory
Baroda Rayon's ITAT Mumbai allowed both its quantum and penalty appeals for AY 2014-15, deleting a ₹12.15 Crore Section 68 addition and a ₹4.13 Crore penalty. The filing updates a pending tax litigation disclosed earlier.
- Value
- ₹12.15 Cr
HD Fire Protect Legal & Regulatory
HD Fire Protect received a GST order dropping a ₹7.10 Crore show-cause demand for FY 2022-23. The order has no financial or operational impact on the company.
- Value
- ₹7.10 Cr
EKI Energy Services Legal & Regulatory
EKI Energy's counterparty Vitol terminated an emission reduction agreement and invoked a USD 10 million bank guarantee. The company disputes the default claim and plans arbitration.
- Value
- ₹94.00 Cr
Mangalore Refinery And Petrochemicals Legal & Regulatory
MRPL received a Customs order demanding ₹1,39,871 plus interest and penalty for 2021 tariff misclassification. The company is considering challenging the order after depositing the money.
- Value
- ₹0.01 Cr
Alfa Ica (India) Legal & Regulatory
Alfa Ica India's board noted a ₹9,440 BSE fine for late Annual Report filing under Regulation 34. The penalty was remitted and stronger compliance tracking was advised.
- Value
- ₹0.00 Cr